JP-1201

N/A

Report date: 2025/02/05 14:37:22
NME

Base Information

Drug NameJP-1201
Drug Alias NameJP-1201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDiablo homolog, mitochondrial modulators
TargetsDiablo homolog, mitochondrial
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJoyant Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJoyant Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A